Xometry (Xometry) Risk Assessment

View and export this data going back to 2021. Start your Free Trial

What is Xometry Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Xometry is: No Data: Cannot be evaluated.

Competitive Comparison of Xometry's Risk Assessment

For the Specialty Industrial Machinery subindustry, Xometry's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xometry's Risk Assessment Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Xometry's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Xometry's Risk Assessment falls into.

Xometry (NAS:XMTR) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Xometry Risk Assessment Related Terms

Thank you for viewing the detailed overview of Xometry's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Xometry (Xometry) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Xometry Inc (NAS:XMTR) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

0N5:Germany

Address

6116 Executive Boulevard, Suite 800, North Bethesda, MD, USA, 20855

Website

https://www.xometry.com

Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as: (1) the U.S. and (2) International. The majority of the revenue is earned from the U.S. segment.

Executives

James M Rallo	officer: Chief Financial Officer	C/O LIQUIDITY SERVICES INC., 1920 L STREET, N.W., 6TH FLOOR, WASHINGTON DC 20036
Matthew Leibel	officer: Chief Technology Officer	7529 STANDISH PLACE, SUITE 200, CO XOMETRY, INC., DERWOOD MD 20855
Bill Cronin	officer: Chief Revenue Officer	180 CONCORD DRIVE, MADISON CT 06824
Emily Rollins	director	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Peter Goguen	officer: Chief Operating Officer	7529 STANDISH PLACE, SUITE 200, DERWOOD MD 20855
George Hornig	director	C/O CREDIT SUISSE FIRST BOSTON PRIVATE, 11 MADISON AVE, NEW YORK NY 10010
Katharine Weymouth	director	1300 NORTH 17TH STREET, SUITE 1700, ARLINGTON VA 22209
Randolph Altschuler	director, officer: Chief Executive Officer	7529 STANDISH PLACE, SUITE 200, DERWOOD MD 20855
Laurence Zuriff	director, officer: Chief Strategy Officer	7529 STANDISH PLACE, SUITE 200, DERWOOD MD 20855
Kathy Mayerhofer	officer: Chief Sales Officer	7529 STANDISH PLACE, SUITE 200, DERWOOD CA 20855
Highland Leaders Fund I, L.p.	10 percent owner	ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Highland Leaders Fund I Gp, Llc	10 percent owner	ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Highland Leaders Fund I Gp, L.p.	10 percent owner	ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Highland Capital Partners 9 Limited Partnership	10 percent owner	ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Highland Capital Partners 9-b Limited Partnership	10 percent owner	ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142